A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer

• Main Authors: Soh, S.X, Siddiqui, F.J, Allen, J.C, Kim, G.W, Lee, J.C, Yatabe, Y, Soda, M, Mano, H, Soo, R.A, Chin, T.-M, Ebi, H, Yano, S, Matsuo, K, Niu, X, Lu, S, Isobe, K, Lee, J.-H, Yang, J.C, Zhao, M, Zhou, C, Lee, J.-K, Lee, S.-H, Lee, J.Y, Ahn, M.-J, Tan, T.J, Tan, D.S, Tan, E.-H, Ong, S.T, Lim, W.-T
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: Impact Journals LLC 2020
• Subjects: BIM protein; epidermal growth factor receptor; erlotinib; gefitinib; age distribution; Article; BIM gene; cancer prognosis; cancer staging; Chinese; EGFR gene; ethnicity; gene deletion; gene frequency; gene linkage disequilibrium; genetic association; genetic variability; genotyping technique; human; Japanese (people); Korean (people); median survival time; non small cell lung cancer; overall survival; progression free survival; sex difference; single nucleotide polymorphism; smoking; survival prediction; systematic review; treatment outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/174901
• Institution: National University of Singapore

10.18632/oncotarget.17102